HNF4A and prostate carcinoma: Intriguingly, we also observed that knockdown of HNF4α could enhance the expression of AR and its variant AR45, and functionally promote the resistance to androgen-deprivation in vitro and in vivo in LNCaP prostate cancer cells (data not shown).